Quentin Koffey / Politan Capital
⭐ Priority · cloneable
· 31-DEC-2025 → 31-MAR-2026
AUM $984,905,664 · 3 positions · top-10 100.0%
· SEC filing history →
13FScore 21/100 — cloning their disclosed top holdings over ~4.4y returned -9%/yr vs S&P +13%/yr (alpha -22%/yr), ahead of the market in 33% of quarters. Cloneable 13F equity book only — excludes hedges/shorts/non-US.
New positions
| Issuer | % book | Value | Since entry | Conviction | Business | Tags |
|---|
| none |
Added to (≥+25% shares)
| Issuer | % book | Δ shares | Since add | Conviction | Business | Tags |
|---|
| none |
Top holdings now
| Issuer | % book | Since entry | Business | Tags |
|---|
| $MASI* · MASIMO CORP | 82.9% | — | Masimo develops and manufactures noninvasive patient monitoring technologies, including pulse oximetry and other sensors and monitors used in hospitals and other care settings, and also makes consumer audio products. | |
| $AZTA · AZENTA INC | 9.9% | -44% Q2 '23 | Azenta provides sample-management and life-science services, including automated cold sample storage, genomic sequencing and gene-synthesis services, and lab consumables for biopharma and research customers. | NASDAQ |
| $CNC · CENTENE CORP DEL | 7.2% | -19% Q4 '21 | Centene is a managed-care organization that provides government-sponsored health insurance, primarily Medicaid, Medicare, and Affordable Care Act marketplace plans. | S&P |